GC
RETA

Guggenheim Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Guggenheim Capital’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,113
Closed -$305K – 1953
2020
Q1 		$305K Sell
2,113
-136
-6% -$19.6K ﹤0.01% 1527
2019
Q4 		$460K Buy
+2,249
New +$460K ﹤0.01% 1625
2019
Q3 		– Sell
-2,314
Closed -$218K – 2167
2019
Q2 		$218K Buy
+2,314
New +$218K ﹤0.01% 2003